Sale!

Ropinirole

A$70.62

-17%
Ropinirole is a prescription medicine used to treat Parkinson's disease and restless legs syndrome. It works by helping to restore the balance of a natural chemical called dopamine in the brain, which can improve movement and reduce symptoms like shaking and discomfort. Always take Ropinirole as directed by your doctor, and discuss any side effects or concerns with your healthcare provider. This medicine is only available with a prescription in Australia.

Ropinirole (Australian Patient Information)

Basic Product Information

International Non-proprietary Name (INN) Ropinirole
Common Australia Brand Names Requip, Adartrel, Ropin, and various generics
ATC Code N04BC04
Available Forms and Strengths Tablets: 0.25 mg, 0.5 mg, 1 mg, 2 mg, 5 mg; Modified-release tablets: 2 mg, 4 mg, 8 mg
Manufacturers in Australia GlaxoSmithKline, Sandoz, Apotex, Arrow Pharmaceuticals
Prescription Status Prescription Only Medicine (Schedule 4, S4)

Mechanism of Action

For Patients: Ropinirole is a type of medicine called a "dopamine agonist." It acts like the natural brain chemical dopamine, which helps control movement and coordination. People with Parkinson’s disease or Restless Legs Syndrome (RLS) may lack dopamine. Ropinirole helps to restore this balance, reducing symptoms such as shakiness, stiffness, and the urge to move your legs.

For Healthcare Professionals: Ropinirole selectively stimulates D2 and D3 dopamine receptors in the striatum, modulating motor activity. It has minimal affinity for serotonergic or adrenergic receptors, reducing risk of common side effects associated with other dopamine agonists.

Pharmacokinetics

  • Absorption: Well absorbed orally; peak plasma levels within 1–2 hours (immediate-release), and 6–10 hours (modified-release).
  • Bioavailability: ~50%. Not significantly affected by food, though fatty meals may prolong absorption slightly.
  • Metabolism: Extensive hepatic metabolism via CYP1A2; metabolites excreted primarily in urine.
  • Elimination: Plasma half-life 6–8 hours (immediate-release); up to 12–14 hours (modified-release).
  • Duration of Action: Once-daily dosing possible with modified-release forms.

Use in Everyday Life and Best Practices

Ropinirole is most commonly prescribed for Parkinson’s disease (to improve mobility and reduce off-periods) and for moderate-to-severe Restless Legs Syndrome (RLS). Typical starting doses are low to reduce side effects, then increased slowly ("titrated") by your doctor.

  • Parkinson’s disease: Usually started at 0.25 mg 3 times daily; gradually increased as advised. Modified-release versions may start at 2 mg once daily.
  • Restless Legs Syndrome: 0.25 mg once daily, 1–3 hours before bedtime; dose titrated as required.

Always follow your Australian healthcare provider’s instructions. It is important to take ropinirole at the same times each day, helping maintain stable levels in your body. If you miss a dose, take it as soon as you remember, but never double up. Keep all appointments for regular review.

Dosing in the Morning vs Evening

  • Morning (Parkinson’s): Immediate-release tablets are often split over the day to keep your symptoms controlled. Modified-release versions are usually taken in the morning, covering the day’s activity.
  • Evening (RLS): The standard time to take ropinirole for RLS is about 1–3 hours before you go to bed, when symptoms are usually worst.
  • Tips: Try to take your medicine at the same times each day for best results. Keep a symptom diary if your doctor suggests adjusting timing.

Taking With Food or on an Empty Stomach

  • Ropinirole can be taken with or without food.
  • Some patients find taking it with a light meal or snack (such as toast or cereal, common in Australia) can help reduce feelings of nausea, a common side effect when starting therapy.
  • Avoid large, fatty meals immediately before taking the tablet, as these may delay absorption slightly (but not the overall effect).
  • It’s safe to drink water, tea, or juice with your tablet.

Interaction Warnings

Item Recommendation Details
Other Medications Check with your pharmacist/doctor May interact with ciprofloxacin, fluvoxamine, hormone replacement therapy, antipsychotics, methadone, oestrogens
Food No major interactions Avoid sudden large increases or decreases in caffeinated drinks
Alcohol Limit or avoid May increase drowsiness or dizziness; affects coordination and safety
Smoking Discuss with your doctor May alter the way your body processes ropinirole (CYP1A2 induction)

Indications

Indication Status Notes
Parkinson’s disease Approved Monotherapy or as adjunct to levodopa
Restless Legs Syndrome (RLS) Approved Moderate to severe primary RLS
Off-label uses* Not formally approved Occasional specialist use (e.g., periodic limb movement disorder)

*Off-label uses should only be considered under specialist advice.

Dosing According to Clinical Indications

Condition & Age Typical Starting Dose Max Daily Dose Notes
Parkinson’s, Adults 0.25 mg 3× daily (IR);
2 mg daily (MR)
24 mg
(lower for elderly)
Titrate every 1–2 weeks as tolerated
RLS, Adults 0.25 mg once daily (1-3 hrs before bedtime) 4 mg Increase if needed after a few days to weeks
Elderly (≥65 years) As above Monitor for greater sensitivity Lower doses or slower titration may be needed
Pediatric Not recommended -- Use in children is not established

Safety Profile and Side Effects

  • Common (may affect 1 in 10 people):
    • Nausea, vomiting, abdominal pain
    • Dizziness, drowsiness, fatigue
    • Low blood pressure, especially when standing (orthostatic hypotension)
    • Constipation
  • Occasionally: Swelling of legs, sleep disturbances, headache, vivid dreams
  • Rare but Serious:
    • Sudden sleep attacks (falling asleep with little warning)
    • Compulsive behaviours (gambling, excessive shopping or eating)
    • Allergic reactions (rash, swelling of lips/tongue, difficulty breathing – seek urgent medical help)
    • Hallucinations, confusion, psychosis (especially in people with history of mental health conditions)
  • Warnings: Do not stop ropinirole suddenly without medical guidance – tapering off is usually advised.

Guidelines for Proper Use (Australia-Specific Advice)

  • Store in the original pack, out of reach of children; at room temperature.
  • Receipt of a prescription is mandatory; repeat scripts may be needed for ongoing treatment.
  • Take your medicine exactly as directed, and use a pillbox or alarm if needed to help you remember.
  • If you feel faint, dizzy, or excessively sleepy, speak to your doctor before driving, cycling, or operating machinery.
  • Tell your doctor if you experience any odd urges or changes in behaviour. These side effects can be managed if detected early.
  • Let every healthcare provider (physiotherapist, pharmacist, dentist, nurse) know you are taking ropinirole.
  • Keep regular reviews with your GP or neurologist—for both dose adjustment and safety monitoring.
  • If you travel, carry your current prescription and a letter from your doctor (for customs if required).
  • Additional support is available from Parkinson’s Australia and RLS Australia community groups.

Alternative Treatment Options in Australia

  • Dopamine Agonists: Pramipexole (Mirapex), rotigotine (Neupro patch)—may be preferred for people unable to tolerate ropinirole tablets.
  • Levodopa/Carbidopa: Considered most effective for Parkinson’s, especially in advanced disease or if ropinirole insufficient.
  • Gabapentin/Pregabalin: Occasionally used for RLS, especially when pain, neuropathy, or intolerance to dopamine agonists.
  • Benzodiazepines: Rarely, very short-term use for severe sleep disruption in RLS.
  • Comparative overview:
    • Ropinirole—well-tolerated, daily oral dosing, long experience in Australia.
    • Pramipexole—similar effect, sometimes more tendency for sleepiness or compulsive disturbances.
    • Levodopa—more short-term benefit in RLS, stronger motor benefit in Parkinson’s, but may lead to long-term motor fluctuations (“on/off” effect).
    • Neupro patch—topical, useful if tablets cause stomach upset.

Legal, Registration, and Reimbursement in Australia

  • TGA Registration: Ropinirole is approved by the Australian Therapeutic Goods Administration (TGA).
  • S4 (Prescription Only): Must be prescribed by a registered medical practitioner.
  • PBS (Pharmaceutical Benefits Scheme) Listing: Subsidised for Parkinson’s disease and for some cases of Restless Legs Syndrome under PBS criteria.
  • Repeat Scripts: Usually issued for long-term therapy, subject to regular review.
  • For more information: Visit TGA.gov.au or pbs.gov.au

Latest Research and Clinical Guidance (2022–2025)

  • Latest Australian guidelines recommend patient-specific titration and close monitoring for impulse control disorders (Australian Therapeutic Guidelines, 2023).
  • Recent studies confirm ropinirole’s effectiveness in long-term management with relatively low risk of dyskinesia (Curr Drug Saf. 2023; Parkinsonism Relat Disord. 2024).
  • Ropinirole remains first-line for RLS, with dosage reduction if augmentation symptoms (worsening of RLS over time) appear (Movement Disorder Society, 2023 update).
  • Special caution for use in elderly and those with moderate-severe hepatic impairment (Ann Neurol. 2022).

Availability, Pack Sizes, and Delivery

Common Pack Size Strength Indicative PBS Price*
30 tablets 0.25 mg, 0.5 mg, 1 mg, 2 mg, 5 mg $6.70 (concession); up to $40.00 (general)
28 modified-release tablets 2 mg, 4 mg, 8 mg $6.70 (concession); up to $40.00 (general)

*Prices as of Q2 2024—subject to PBS conditions.

Delivery Times (Direct-to-Customer, Australia-wide)

City/Region Standard Delivery Express Delivery
Sydney, Melbourne 1–2 business days Same/next day
Brisbane, Adelaide 2 business days Next day
Perth, Darwin 3–4 business days 1–2 days
Regional/remote areas 4–6 business days 2–3 days

Frequently Asked Questions (FAQ)

1. How long does it take for ropinirole to work?

Many people notice some symptom improvement within a week, but it may take a few weeks to reach the full effect as your dose is slowly increased. For RLS, some experience relief within the first few nights.

2. What should I do if I miss a dose?

If you miss a dose, take it as soon as you remember unless it’s nearly time for your next dose. Do not double doses to make up for a missed one. If unsure, contact your pharmacy or clinic for advice.

3. Can I drink alcohol while taking ropinirole?

Avoid or limit alcohol. It can increase the risk of side effects like drowsiness, dizziness, and reduce your coordination. If you drink, do so in moderation and never drive or operate machinery after drinking alcohol with this medication.

4. Is ropinirole safe during pregnancy or breastfeeding?

Ropinirole is not generally recommended during pregnancy or breastfeeding unless the expected benefits outweigh the risks. Please talk to your doctor for individual advice.

5. Will I need to take ropinirole forever?

This depends on your specific condition and how you respond to treatment. Some people need long-term therapy, while others may switch to other medications as their condition changes. Never stop taking ropinirole without consulting your doctor first.

For more support, speak with your pharmacist or your treating specialist, or visit Parkinson’s Australia (parkinsons.org.au) or RLS Australia (rlsaustralia.org.au).

Additional information

Dosage: No selection

0.25mg, 0.5mg, 1mg, 2mg

Package: No selection

30 pill, 60 pill, 90 pill, 120 pill, 180 pill, 360 pill